-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES PIMJETMI® (PIMICOTINIB) FOR PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

Reuters·11/10/2026 19:23:05

Please log in to view news